Argent Trust Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.33M | Sell |
8,397
-100
| -1% | -$13.5K | 0.04% | 319 |
|
|
2026
Q1 | $1.09M | Hold |
8,497
| – | – | 0.04% | 334 |
|
|
2025
Q4 | $1.04M | Buy |
8,497
+1,795
| +27% | +$206K | 0.04% | 330 |
|
|
2025
Q3 | $672K | Sell |
6,702
-150
| -2% | -$13.5K | 0.02% | 400 |
|
|
2025
Q2 | $568K | Sell |
6,852
-3,230
| -32% | -$258K | 0.02% | 422 |
|
|
2025
Q1 | $818K | Sell |
10,082
-146
| -1% | -$13.1K | 0.03% | 341 |
|
|
2024
Q4 | $921K | Sell |
10,228
-575
| -5% | -$55.7K | 0.04% | 308 |
|
|
2024
Q3 | $1.07M | Buy |
10,803
+3,562
| +49% | +$350K | 0.04% | 306 |
|
|
2024
Q2 | $671K | Sell |
7,241
-400
| -5% | -$35.9K | 0.03% | 369 |
|
|
2024
Q1 | $725K | Sell |
7,641
-38
| -0.5% | -$3.53K | 0.03% | 359 |
|
|
2023
Q4 | $686K | Sell |
7,679
-8,528
| -53% | -$633K | 0.03% | 353 |
|
|
2023
Q3 | $1.18M | Buy |
16,207
+9,675
| +148% | +$773K | 0.06% | 248 |
|
|
2023
Q2 | $543K | Sell |
6,532
-66
| -1% | -$5.52K | 0.03% | 385 |
|
|
2023
Q1 | $503K | Sell |
6,598
-40
| -0.6% | -$3.32K | 0.03% | 348 |
|
|
2022
Q4 | $551K | Hold |
6,638
| – | – | 0.04% | 330 |
|
|
2022
Q3 | $527K | Sell |
6,638
-556
| -8% | -$46.9K | 0.04% | 325 |
|
|
2022
Q2 | $534K | Sell |
7,194
-90
| -1% | -$6.76K | 0.04% | 331 |
|
|
2022
Q1 | $655K | Sell |
7,284
-15
| -0.2% | -$1.39K | 0.04% | 315 |
|
|
2021
Q4 | $817K | Sell |
7,299
-1,200
| -14% | -$145K | 0.05% | 288 |
|
|
2021
Q3 | $1.07M | Hold |
8,499
| – | – | 0.07% | 233 |
|
|
2021
Q2 | $1.15M | Sell |
8,499
-27
| -0.3% | -$3.55K | 0.08% | 216 |
|
|
2021
Q1 | $1.16M | Buy |
8,526
+32
| +0.4% | +$4.79K | 0.08% | 216 |
|
|
2020
Q4 | $1.2M | Sell |
8,494
-149
| -2% | -$19.1K | 0.09% | 193 |
|
|
2020
Q3 | $963K | Sell |
8,643
-33
| -0.4% | -$3.7K | 0.08% | 201 |
|
|
2020
Q2 | $971K | Hold |
8,676
| – | – | 0.09% | 198 |
|
|
2020
Q1 | $672K | Sell |
8,676
-979
| -10% | -$86.7K | 0.08% | 221 |
|
|
2019
Q4 | $918K | Hold |
9,655
| – | – | 0.08% | 217 |
|
|
2019
Q3 | $736K | Sell |
9,655
-9
| -0.1% | -$748 | 0.07% | 242 |
|
|
2019
Q2 | $848K | Hold |
9,664
| – | – | 0.09% | 213 |
|
|
2019
Q1 | $875K | Hold |
9,664
| – | – | 0.09% | 202 |
|
|
2018
Q4 | $693K | Buy |
9,664
+30
| +0.3% | +$2.42K | 0.08% | 217 |
|
|
2018
Q3 | $908K | Sell |
9,634
-6
| -0.1% | -$582 | 0.1% | 179 |
|
|
2018
Q2 | $917K | Buy |
+9,640
| New | +$886K | 0.11% | 181 |
|
Other funds holding XBI
JFG
Argent Trust Co's XBI Position: Q2 2026 in Review
Argent Trust Co reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.2% in Q2 2026, selling an estimated $13.5K and leaving 8,397 shares worth $1.33M. The position accounts for 0.04% of the portfolio, ranked #319.
Argent Trust Co first reported a position in XBI in Q2 2018 and has held it in 33 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Argent Trust Co held 8,397 shares of State Street SPDR S&P Biotech ETF worth $1.33M as of Q2 2026.
- Argent Trust Co sold 100 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $13.5K.
- State Street SPDR S&P Biotech ETF made up 0.04% of Argent Trust Co's portfolio in Q2 2026, its #319 holding.
- Argent Trust Co first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 33 quarters since.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.